Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NIDA-CTO-0004

Division

DTMC

HEAL Study

Investigator(s)

Thomas F. Newton, M.D.

Title

Assessment Of Potential Interactions Between Intravenous Methamphetamine And Oral Selegiline

Short Description

This is a human laboratory clinical pharmacology study to assess potential interactions between intravenous methamphetamine challenge and treatment with oral selegiline.

Release Date

Aug 01, 2016

Description

The primary objective of this study is to determine the safety of the selegiline concurrent with dmethamphetamine challenges of 15 mg and 30 mg i.v. The primary outcome measures are cardiovascular responses (HR, BP) to the i.v. methamphetamine challenges.

Keywords

Assessments

Beck Depression Inventory

Blood Methamphetamine Level

Blood Study Agent Level

Brief Symptom Inventory

ECG Monitoring